Attenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Inuzuka, Takayuki ^a   Fujioka, Yoichiro ^a   Tsuda, Masumi ^a   Fujioka, Mari ^a   Satoh, Aya O ^a   Horiuchi, Kosui ^a   Nishide, Shinya ^a   Nanbo, Asuka ^a   Tanaka, Shinya ^a   Ohba, Yusuke ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; PROTEIN KINASE C;

CELL MEMBRANE; ENDOSOME; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL MEMBRANE; ENDOSOMES; FLUORESCENCE RESONANCE ENERGY TRANSFER; HELA CELLS; HUMANS; PROTEIN KINASE C; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION;

EID: 84957575541     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21613     Document Type: Article

References (35)

1. Kim, S. & Iwao, H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52, 11-34 (2000).
2. Mehta, P. K. & Griendling, K. K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292, C82-97 (2007).
3. Yoshida, T. et al. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: Potential therapeutic targets for cardiac cachexia. Int J Biochem Cell Biol 45, 2322-2332 (2013).
4. Munzenmaier, D. H. & Greene, A. S. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 27, 760-765 (1996).
5. Bedecs, K. et al. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J 325 (Pt 2), 449-454 (1997).
6. Matsubara, H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83, 1182-1191 (1998).
7. Steckelings, U. M., Kaschina, E. & Unger, T. The AT2 receptor-a matter of love and hate. Peptides 26, 1401-1409 (2005).
8. Stoll, M. et al. Identification of a zinc finger homoeodomain enhancer protein after AT(2) receptor stimulation by differential mRNA display. Arterioscler Thromb Vasc Biol 22, 231-237 (2002).
9. AbdAlla, S., Lother, H., Abdel-tawab, A. M. & Quitterer, U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276, 39721-39726 (2001).
10. Shcherbo, D. et al. Near-infrared fluorescent proteins. Nat Methods 7, 827-829 (2010).
11. 2+ mobilization. Am J Physiol Renal Physiol 302, F875-83 (2012).
12. Hein, L., Meinel, L., Pratt, R. E., Dzau, V. J. & Kobilka, B. K. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol 11, 1266-1277 (1997).
13. Turu, G. et al. Differential beta-arrestin binding of AT1 and AT2 angiotensin receptors. FEBS Lett 580, 41-45 (2006).
14. Kawai, T. et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5, 1061-1068 (2004).
15. Li, X., Lee, J. W., Graves, L. M. & Earp, H. S. Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway. EMBO J 17, 2574-2583 (1998).
16. Luttrell, L. M. Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors. Can J Physiol Pharmacol 80, 375-382 (2002).
17. Lorenz, K., Schmitt, J. P., Schmitteckert, E. M. & Lohse, M. J. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat Med 15, 75-83 (2009).
18. Mehta, M., Ali, Z., Prabhakar, H. & Singh, G. P. Low bispectral index values after treatment for seizures in Dandy-Walker syndrome. Paediatr Anaesth 19, 628-629 (2009).
19. Lee, M. H., El-Shewy, H. M., Luttrell, D. K. & Luttrell, L. M. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription. J Biol Chem 283, 2088-2097 (2008).
20. Yayama, K. et al. Up-regulation of angiotensin II type 2 receptor in rat thoracic aorta by pressure-overload. J Pharmacol Exp Ther 308, 736-743 (2004).
21. Moltzer, E., Verkuil, A. V. A., van Veghel, R., Danser, A. H. J. & van Esch, J. H. M. Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation. Hypertension 55, 516-522 (2010).
22. Scheuer, D. A. & Perrone, M. H. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am J Physiol 264, R917-23 (1993).
23. Hein, L., Barsh, G. S., Pratt, R. E., Dzau, V. J. & Kobilka, B. K. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377, 744-747 (1995).
24. Tsutsumi, Y. et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 104, 925-935 (1999).
25. Ichihara, S. et al. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 104, 346-351 (2001).
26. Viswanathan, M., Tsutsumi, K., Correa, F. M. & Saavedra, J. M. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 179, 1361-1367 (1991).
27. Henrion, D., Kubis, N. & Lévy, B. I. Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension 38, 1150-1157 (2001).
28. Miura, S.-I., Matsuo, Y., Kiya, Y., Karnik, S. S. & Saku, K. Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors. Biochem Biophys Res Commun 391, 85-90 (2010).
29. Senbonmatsu, T. et al. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J 22, 6471-6482 (2003).
30. Abadir, P. M., Periasamy, A., Carey, R. M. & Siragy, H. M. Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension 48, 316-322 (2006).
31. Sasamura, H., Hein, L., Saruta, T. & Pratt, R. E. Evidence for internalization of both type 1 angiotensin receptor subtypes (AT1a, AT1b) by a protein kinase C independent mechanism. Hypertens Res 20, 295-300 (1997).
32. Olivares-Reyes, J. et al. Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors. Mol Pharmacol 68, 356-364 (2005).
33. Ishida, J. et al. Expression and characterization of mouse angiotensin II type 1a receptor tagging hemagglutinin epitope in cultured cells. Int J Mol Med 3, 263-270 (1999).
34. Inuzuka, T., Tsuda, M., Kawaguchi, H. & Ohba, Y. Transcription factor 8 activates R-Ras to regulate angiogenesis. Biochem Biophys Res Commun 379, 510-513 (2009).
35. Honda, K. et al. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 101, 15416-15421 (2004).